Synthetic Lethal Interaction between Oncogenic KRAS Dependency and STK33 Suppression in Human Cancer Cells
Claudia Scholl, Stefan Fröhling, Ian F. Dunn et al. · Cell · 2009
Cited by 538 works. doi:10.1016/j.cell.2009.03.017 Open-access PDF
Authors
- Claudia Scholl
- Stefan Fröhling
- Ian F. Dunn
- Anna C. Schinzel
- David Allen Barbie
- So Young Kim
- Serena J. Silver
- Pablo Tamayo
- Raymond Couric Wadlow
- Sridhar Ramaswamy
- Konstanze Döhner
- Lars Bullinger
- Péter Sandy
- Jesse S. Boehm
- David E. Root
- Tyler Jacks
- William C. Hahn
- D. Gary Gilliland
References
- An Integrated Genomic Analysis of Human Glioblastoma Multiforme
- Patterns of somatic mutation in human cancer genomes
- Serine Phosphorylation of Death Agonist BAD in Response to Survival Factor Results in Binding to 14-3-3 Not BCL-XL
- Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
- The Genomic Landscapes of Human Breast and Colorectal Cancers
- mTOR Interacts with Raptor to Form a Nutrient-Sensitive Complex that Signals to the Cell Growth Machinery
- BRAF mutation predicts sensitivity to MEK inhibition
- The Biology of Cancer: Metabolic Reprogramming Fuels Cell Growth and Proliferation
- A Lentiviral RNAi Library for Human and Mouse Genes Applied to an Arrayed Viral High-Content Screen
- Oncogenic pathway signatures in human cancers as a guide to targeted therapies